| Target Price | $23.92 |
| Price | $18.34 |
| Potential |
30.42%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Sotera Health Co 2027 .
The average Sotera Health Co target price is $23.92.
This is
30.42%
register free of charge
$26.25
43.13%
register free of charge
$22.22
21.16%
register free of charge
|
|
| A rating was issued by 15 analysts: 12 Analysts recommend Sotera Health Co to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sotera Health Co stock has an average upside potential 2027 of
30.42%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.16 | 1.26 |
| 5.74% | 8.20% | |
| EBITDA Margin | 33.75% | 51.28% |
| 3.27% | 51.92% | |
| Net Margin | 6.70% | 22.54% |
| 66.26% | 236.47% |
12 Analysts have issued a sales forecast Sotera Health Co 2026 . The average Sotera Health Co sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Sotera Health Co EBITDA forecast 2026. The average Sotera Health Co EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Sotera Health Co Analysts have issued a net profit forecast 2026. The average Sotera Health Co net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.27 | 0.99 |
| 68.75% | 266.67% | |
| P/E | 18.44 | |
| EV/Sales | 5.65 |
12 Analysts have issued a Sotera Health Co forecast for earnings per share. The average Sotera Health Co EPS is
This results in the following potential growth metrics and future valuations:
Sotera Health Co...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Jun 24 2026 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Jun 05 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 06 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jun 24 2026 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Jun 05 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 06 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


